These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34496447)

  • 41. Effectiveness and cost effectiveness of cognitive behavioral therapy (CBT) in clinically depressed adolescents: individual CBT versus treatment as usual (TAU).
    Stikkelbroek Y; Bodden DH; Deković M; van Baar AL
    BMC Psychiatry; 2013 Nov; 13():314. PubMed ID: 24261913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost and Effectiveness of Blended Versus Standard Cognitive Behavioral Therapy for Outpatients With Depression in Routine Specialized Mental Health Care: Pilot Randomized Controlled Trial.
    Kooistra LC; Wiersma JE; Ruwaard J; Neijenhuijs K; Lokkerbol J; van Oppen P; Smit F; Riper H
    J Med Internet Res; 2019 Oct; 21(10):e14261. PubMed ID: 31663855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-effectiveness analysis of cognitive behaviour therapy for treatment of minor or mild-major depression in elderly patients with type 2 diabetes: study protocol for the economic evaluation alongside the MIND-DIA randomized controlled trial (MIND-DIA CEA).
    Chernyak N; Petrak F; Plack K; Hautzinger M; Müller MJ; Giani G; Icks A
    BMC Geriatr; 2009 Jul; 9():25. PubMed ID: 19570236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Web-based guided self-help for employees with depressive symptoms (Happy@Work): design of a randomized controlled trial.
    Geraedts AS; Kleiboer AM; Wiezer NM; van Mechelen W; Cuijpers P
    BMC Psychiatry; 2013 Feb; 13():61. PubMed ID: 23418886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and cost-effectiveness of two online interventions for children and adolescents at risk for depression (E.motion trial): study protocol for a randomized controlled trial within the ProHEAD consortium.
    Baldofski S; Kohls E; Bauer S; Becker K; Bilic S; Eschenbeck H; Kaess M; Moessner M; Salize HJ; Diestelkamp S; Voß E; Rummel-Kluge C;
    Trials; 2019 Jan; 20(1):53. PubMed ID: 30646944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-utility of a guided Internet-based intervention in comparison with attention only for people with HIV and depressive symptoms: A randomized controlled trial.
    van Luenen S; Kraaij V; Garnefski N; Spinhoven P; van den Akker-van Marle ME
    J Psychosom Res; 2019 Mar; 118():34-40. PubMed ID: 30782352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a school-based depression prevention program among adolescents with elevated depressive symptoms: study protocol of a randomized controlled trial.
    de Jonge-Heesen KW; van Ettekoven KM; Rasing SP; Liempd FH; Vermulst AA; Engels RC; Creemers DH
    BMC Psychiatry; 2016 Nov; 16(1):402. PubMed ID: 27852295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. (Cost)-effectiveness of family meetings on indicated prevention of anxiety and depressive symptoms and disorders of primary family caregivers of patients with dementia: design of a randomized controlled trial.
    Joling KJ; van Hout HP; Scheltens P; Vernooij-Dassen M; van den Berg B; Bosmans J; Gillissen F; Mittelman M; van Marwijk HW
    BMC Geriatr; 2008 Jan; 8():2. PubMed ID: 18208607
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the cost effectiveness of escitalopram versus venlafaxine XR in major depressive disorder.
    Fernandez JL; Montgomery S; Francois C
    Pharmacoeconomics; 2005; 23(2):155-67. PubMed ID: 15748090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
    Cruess AF; Zlateva G; Xu X; Soubrane G; Pauleikhoff D; Lotery A; Mones J; Buggage R; Schaefer C; Knight T; Goss TF
    Pharmacoeconomics; 2008; 26(1):57-73. PubMed ID: 18088159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.
    Daley M; Morin CM; LeBlanc M; Grégoire JP; Savard J
    Sleep; 2009 Jan; 32(1):55-64. PubMed ID: 19189779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preventing Depression in Adults With Subthreshold Depression: Health-Economic Evaluation Alongside a Pragmatic Randomized Controlled Trial of a Web-Based Intervention.
    Buntrock C; Berking M; Smit F; Lehr D; Nobis S; Riper H; Cuijpers P; Ebert D
    J Med Internet Res; 2017 Jan; 19(1):e5. PubMed ID: 28052841
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic evaluation of stepped-care versus usual care for depression and anxiety in older adults with vision impairment: randomized controlled trial.
    van der Aa HPA; van Rens GHMB; Bosmans JE; Comijs HC; van Nispen RMA
    BMC Psychiatry; 2017 Aug; 17(1):280. PubMed ID: 28764679
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.
    Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J
    BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The societal costs of problem gambling in Sweden.
    Hofmarcher T; Romild U; Spångberg J; Persson U; Håkansson A
    BMC Public Health; 2020 Dec; 20(1):1921. PubMed ID: 33339531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-utility of collaborative care for major depressive disorder in primary care in the Netherlands.
    Goorden M; Huijbregts KM; van Marwijk HW; Beekman AT; van der Feltz-Cornelis CM; Hakkaart-van Roijen L
    J Psychosom Res; 2015 Oct; 79(4):316-23. PubMed ID: 26255095
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Global prevalence of depression and elevated depressive symptoms among adolescents: A systematic review and meta-analysis.
    Shorey S; Ng ED; Wong CHJ
    Br J Clin Psychol; 2022 Jun; 61(2):287-305. PubMed ID: 34569066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Subclinical depression: a clinically relevant condition?].
    Cuijpers P; Smit F
    Tijdschr Psychiatr; 2008; 50(8):519-28. PubMed ID: 18688776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.